TRANS GENIC GROUP INC. (2342) Other
Market cap
¥3.6B
P/E ratio
23.8x
Transgenics Group supports drug development through specialized lab services like genetically modified mice production and pharmaceutical testing, while also providing business consulting and importing various products from electrical equipment to tableware.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 3.6 | 2.3 | 1.9 | 3.3 | -5.9 | 6.6 | 19.4 | -3.9 | 0.5 | -8.2 | -0.8 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 30 | 32 | 132 | 132 | 141 | 137 | 162 | 223 | 250 | 248 | 213 | 236 | 236 | 241 | 227 |
| Total payout ratio | - | - | - | - | - | - | - | - | - | - | 18.7 | - | 3,976.4 | - | - |